OurCrowd Portfolio Company Zebra Medical Gains 5th FDA Clearance, OurCrowd Predicts Renaissance in Medical Innovation
OurCrowd portfolio company Zebra Medical Vision, a deep-learning Medtech company, has announced its fifth FDA 510(k) clearance for its Vertebral Compression Fractures (VCF) product. The VCF product expands the company’s growing “AI1” (all-in-one) bundle of FDA cleared AI solutions. The company explains that nearly half… Read More
Read more in: Global, Investment Platforms and Marketplaces, Offerings | Tagged coronavirus, covid-19, israel, kyron, medtech, migvax, ourcrowd, zebra medical vision
